May 10th, 2023 – South San Francisco, CA – Genetech Press Release Acceptance based on two Phase III studies that demonstrated early and sustained vision improvement with Vabysmo, meeting primary endpoint of non-inferiority compared to aflibercept Application was further supported…
Tag: Vabysmo
New Phase III Data Show Genentech’s Vabysmo Rapidly Improved Vision and More
February 9th, 2023 – South San Francisco, CA Genetech Press Release New Phase III Data Show Genentech’s Vabysmo Rapidly Improved Vision and Reduced Retinal Fluid in People With Retinal Vein Occlusion (RVO) Vabysmo met its primary endpoint in two clinical…